Dorothea Schott

Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors

Dorothea Schott, Monika Pizon, Ulrich Pachmann et al. · Oncotarget · 2017 · 56 citations · Full text

Medicine, Immunology, Oncology +17

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients

Monika Pizon, Dorothea Schott, Ulrich Pachmann et al. · Cancers · 2022 · 33 citations · Full text

Medicine, Cell Biology, Oncology +17

B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients

Monika Pizon, Dorothea Schott, Ulrich Pachmann et al. · International Journal of Oncology · 2018 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia

W.-K. Hofmann, G. Seipelt, S. Langenhan et al. · Annals of Hematology · 2002 · 21 citations

Medicine, Oncology, Pharmacology +16

Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer

Matthias Mäurer, Dorothea Schott, Monika Pizon et al. · Current Oncology · 2022 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +17